Breast and gynecological cancers in Croatia, 1988-2008
نویسندگان
چکیده
منابع مشابه
Breast and gynecological cancers in Croatia, 1988-2008
AIM To analyze and interpret incidence and mortality trends of breast and ovarian cancers and incidence trends of cervical and endometrial cancers in Croatia for the period 1988-2008. METHODS Incidence data were obtained from the Croatian National Cancer Registry. Themortality data were obtained from the World Health Organization (WHO) mortality database. Trends of incidence and mortality wer...
متن کاملIncidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008 CANCER EPIDEMIOLOGY
Results Gastric cancer incidence rates declined steadily during the study period, with estimated annual percent change (EAPC) of -3.2% for men and -2.8% for women. Mortality rates in men decreased, with EAPC of -5.0% from 1988-1995 and -2.5% from 1995-2008. Mortality rates in women decreased, with EAPC of -3.2% throughout the study period. For colorectal cancer in men, joinpoint analysis reveal...
متن کاملIncidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008
AIM To estimate the incidence and mortality trends of gastric and colorectal cancers in Croatia between 1988 and 2008. METHODS Incidence data for the period 1988-2008 were obtained from the Croatian National Cancer Registry. The number of deaths from gastric and colorectal cancers were obtained from the World Health Organization mortality database. Joinpoint regression analysis was used to de...
متن کاملIncidence and mortality trends of melanoma in Croatia, 1988-2008
AIM To analyze melanoma incidence and mortality trends in Croatia 1988-2008, compare them with the trends in other populations, and identify possible changes in the trends. METHODS Incidence data were obtained from the Croatian National Cancer Registry and the mortality data from the Croatian Bureau of Statistics. United Nations population estimates were used for calculating the age-specific ...
متن کاملGnRH antagonists in the treatment of gynecological and breast cancers.
Approximately 80% of human ovarian and endometrial cancers and 50% of breast cancers express GnRH and its receptor as part of an autocrine regulatory system. After binding of its ligand the tumor GnRH receptor couples to G-protein alphai and activates a variety of intracellular signaling mechanisms. (1) Through activation of a protein tyrosine phosphatase, autophosphorylation of growth factor r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Croatian Medical Journal
سال: 2012
ISSN: 0353-9504,1332-8166
DOI: 10.3325/cmj.2012.53.100